IC
ANIP icon

Ikarian Capital’s ANI Pharmaceuticals ANIP Stock Holding History

Ikarian Capital’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.5M Buy
150,000
+67,200
+81% +$5.25M 0.94% 28
2025
Q4 		$6.54M Buy
+82,800
New +$7.17M 0.51% 56

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ikarian Capital's ANIP Position: Q1 2026 in Review

Ikarian Capital opened a new position in ANI Pharmaceuticals (ANIP) in Q1 2026: 147,085 shares worth $11.3M. The stake represents 0.92% of the portfolio and ranks #31 among its holdings.

280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Ikarian Capital held 147,085 shares of ANI Pharmaceuticals worth $11.3M as of Q1 2026.
  • ANI Pharmaceuticals was a new Ikarian Capital position in Q1 2026.
  • ANI Pharmaceuticals made up 0.92% of Ikarian Capital's portfolio in Q1 2026, its #31 holding.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.